These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20432619)

  • 21. Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.
    Pastorino F; Mumbengegwi DR; Ribatti D; Ponzoni M; Allen TM
    J Control Release; 2008 Feb; 126(1):85-94. PubMed ID: 18166243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled release of doxorubicin from thermosensitive poly(organophosphazene) hydrogels.
    Kang GD; Cheon SH; Song SC
    Int J Pharm; 2006 Aug; 319(1-2):29-36. PubMed ID: 16677786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice.
    Mizuno Y; Naoi T; Nishikawa M; Rattanakiat S; Hamaguchi N; Hashida M; Takakura Y
    J Control Release; 2010 Jan; 141(2):252-9. PubMed ID: 19778560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of factors affecting in vitro doxorubicin release from PEGylated liposomal doxorubicin for the development of in vitro release testing conditions.
    Shibata H; Izutsu K; Yomota C; Okuda H; Goda Y
    Drug Dev Ind Pharm; 2015; 41(8):1376-86. PubMed ID: 25170659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigations on the antitumor efficacy of liposome-associated doxorubicin in murine tumor models.
    Gabizon A; Goren D; Barenholz Y
    Isr J Med Sci; 1988; 24(9-10):512-7. PubMed ID: 3204005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposome-based intracellular kinetics of doxorubicin in K562/DOX cells.
    Xu DH; Gao JQ; Liang WQ
    Pharmazie; 2008 Sep; 63(9):646-9. PubMed ID: 18819516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo.
    Gubernator J; Chwastek G; Korycińska M; Stasiuk M; Grynkiewicz G; Lewrick F; Süss R; Kozubek A
    J Control Release; 2010 Aug; 146(1):68-75. PubMed ID: 20510316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. General and cardiac toxicity of doxorubicin-loaded gelatin nanoparticles.
    Leo E; Arletti R; Forni F; Cameroni R
    Farmaco; 1997; 52(6-7):385-8. PubMed ID: 9372590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model.
    Storm G; Roerdink FH; Steerenberg PA; de Jong WH; Crommelin DJ
    Cancer Res; 1987 Jul; 47(13):3366-72. PubMed ID: 3581073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of gene expression by transcriptional activation using doxorubicin-loaded liposome/pDNA complexes.
    Un K; Kono Y; Yoshida M; Yamashita F; Kawakami S; Hashida M
    Pharmazie; 2012 May; 67(5):400-5. PubMed ID: 22764571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct, simultaneous measurement of liposome-encapsulated and released drugs in plasma by on-line SPE-SPE-HPLC.
    Yamamoto E; Hyodo K; Ohnishi N; Suzuki T; Ishihara H; Kikuchi H; Asakawa N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3620-5. PubMed ID: 22030453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques.
    Mayer LD; St-Onge G
    Anal Biochem; 1995 Dec; 232(2):149-57. PubMed ID: 8747469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts.
    Sakakibara T; Chen FA; Kida H; Kunieda K; Cuenca RE; Martin FJ; Bankert RB
    Cancer Res; 1996 Aug; 56(16):3743-6. PubMed ID: 8706018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.
    van Hoesel QG; Steerenberg PA; Crommelin DJ; van Dijk A; van Oort W; Klein S; Douze JM; de Wildt DJ; Hillen FC
    Cancer Res; 1984 Sep; 44(9):3698-705. PubMed ID: 6744286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caspase-3 activation during apoptosis caused by glutathione-doxorubicin conjugate.
    Asakura T; Sawai T; Hashidume Y; Ohkawa Y; Yokoyama S; Ohkawa K
    Br J Cancer; 1999 May; 80(5-6):711-5. PubMed ID: 10360648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.